KPV Inflammation • Gut • Immune Optimization

KPV is a tripeptide (Lysine-Proline-Valine) that represents the carboxy-terminal tail of the anti-inflammatory hormone alpha-melanocyte-stimulating hormone (α-MSH). It is extensively studied for its potent, localized anti-inflammatory and immune-modulating effects, particularly in the gut. Its primary benefits include supporting mucosal healing, reducing chronic inflammation in conditions like inflammatory bowel disease (IBD), and helping to maintain the integrity of the intestinal barrier. <br><br> The mechanism of action for KPV is primarily intracellular, which allows it to act with high efficacy across various tissues. It modulates the inflammatory response by inhibiting the activation of the NF-κB pathway—the body's master regulator of inflammatory gene expression. By downregulating the production of pro-inflammatory cytokines such as TNF-α and IL-1β, KPV calms excessive immune system activation while preserving the ability of the immune system to respond to genuine pathogens. <br><br> Research backing for KPV includes significant preclinical data in models of colitis, dermatitis, and other inflammatory disorders. The research highlights that because of its small size, KPV can cross cell membranes efficiently, making it a versatile tool for both oral and topical applications. Its ability to restore intestinal barrier function and modulate gut flora makes it a focus of modern research into the treatment of "leaky gut" and other chronic inflammatory conditions.